12/19
08:27 am
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $1.50 price target on the stock, up previously from $1.00.
High
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $1.50 price target on the stock, up previously from $1.00.
12/19
08:27 am
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $1.50 price target on the stock, up previously from $1.00.
High
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $1.50 price target on the stock, up previously from $1.00.
12/19
08:10 am
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
High
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
12/19
07:49 am
cgtx
Rating for CGTX
Low
Report
Rating for CGTX
12/19
07:04 am
cgtx
Cognition Therapeutics upgraded to Buy from Neutral at B. Riley
High
Report
Cognition Therapeutics upgraded to Buy from Neutral at B. Riley
12/19
07:04 am
cgtx
Cognition Therapeutics upgraded to Buy from Neutral at B. Riley
High
Report
Cognition Therapeutics upgraded to Buy from Neutral at B. Riley
11/27
08:05 am
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Medium
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
11/15
06:04 pm
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
Low
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
11/15
05:38 pm
cgtx
Rating for CGTX
Low
Report
Rating for CGTX
11/4
08:19 am
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
10/31
10:42 am
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
Low
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $11.00 price target on the stock.
10/31
09:55 am
cgtx
Rating for CGTX
Medium
Report
Rating for CGTX